Doxorubicin liposome
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Doxorubicin liposome, covering 2024-12-31 to 2024-12-31. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Multicenter, Single-arm Clinical Study on the Use of Doxorubicin Liposome in Combination With CapOX and Bevacizumab Regimen for First-line Treatment of Advanced Colorectal Adenocarcinoma With SMAD4R361H/C Mutation. [Phase 1, Phase 2]